Literature DB >> 6057934

Growth of 2 human tumour cell lines in mice treated with antilymphocyte serum.

B Phillips, J C Gazet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6057934     DOI： 10.1038/215548a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Characterization of the WIDR: a human colon carcinoma cell line.

Authors:  P Noguchi; R Wallace; J Johnson; E M Earley; S O'Brien; S Ferrone; M A Pellegrino; J Milstien; C Needy; W Browne; J Petricciani
Journal:  In Vitro       Date:  1979-06

2.  Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation.

Authors:  E Simpson; S L Nehlsen
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

Review 3.  Anti-lymphocytic antibody and autoimmune disease: a review.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

4.  A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum.

Authors:  G J Todaro; P Arnstein; W P Parks; E H Lennette; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

5.  Human myeloma marrow cells in immunologically deficient mice.

Authors:  D N Mitchell; R J Rees; A J Salsbury
Journal:  Br J Cancer       Date:  1974-07       Impact factor: 7.640

6.  Long-term survival of HeLa tumours in mice treated with antilymphocyte serum.

Authors:  C R Franks; K Curtis; F T Perkins
Journal:  Br J Cancer       Date:  1973-05       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.